The risk of varicella zoster virus infection in multiple sclerosis patients treated with fingolimod

Clinical Neurology

Volumn 56, Issue 4, 2016, Pages 270-272

  Tanaka, Masami ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Fingolimod; Multiple sclerosis; Neuromyelitis optica; Tacrolimus; Varicella zoster virus

Indexed keywords

FINGOLIMOD; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN ANTIBODY; TACROLIMUS; TOFACITINIB; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; ASIAN; EUROPEAN; HEMIANOPIA; HERPES ZOSTER; HUMAN; INCIDENCE; INFECTION RISK; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NONHUMAN; RHEUMATOID ARTHRITIS; SALIVA; UNITED STATES; VIRUS REACTIVATION; ADULT; AGED; FEMALE; IMMUNOCOMPROMISED PATIENT; MALE; MIDDLE AGED; RECURRENT DISEASE; SECONDARY PREVENTION;

ADULT; AGED; FEMALE; FINGOLIMOD HYDROCHLORIDE; HERPES ZOSTER; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECURRENCE; SECONDARY PREVENTION;

EID: 84964967741     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.cn-000809     Document Type: Article

References (9)

1. Francis G, Kappos L, O'Connor P, et al. Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy. Mult Scler 2014;20:471-480.
2. Arvin AM, Wolinsky JS, Kappos L, et al. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. JAMA Neurol 2015;72:31-39.
3. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177-189.
4. Tanaka M, Tanaka K. Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system. J Neuroimmunol 2014;270:98-99.
5. Tanaka M, Kinoshita M, Tanaka K. Corticosteroid and tacrolimus treatment in neuromyelitis optica related disorders. Mult Scler 2015;21:669.
6. Tanaka K, Tani T, Tanaka M, et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007;13:850-855.
7. Ricklin ME, Lorscheider J, Waschbisch A, et al. T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology 2013;81:174-181.
8. Winthrop KL, Yamanaka H, Valdez H, et al. Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis. Arthritis Rheumatol 2014;66:2675-2684.
9. Takao Y, Miyazaki Y, Okeda M, et al. Incidences of herpes zoster and postherpetic neuralgia in japanese adults aged 50 years and older from a community-based prospective cohort study: The SHEZ study. J Epidemiol 2015;25:617-625.